SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer - PubMed (original) (raw)
. 2003 May 15;22(19):2972-83.
doi: 10.1038/sj.onc.1206474.
Affiliations
- PMID: 12771949
- DOI: 10.1038/sj.onc.1206474
SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer
Constanze Zeller et al. Oncogene. 2003.
Abstract
Loss of heterozygosity (LOH) and in silico expression analysis were applied to identify genes significantly downregulated in breast cancer within the genomic interval 6q23-25. Systematic comparison of candidate EST sequences with genomic sequences from this interval revealed the genomic structure of a potential target gene on 6q24.3, which we called SAM and SH3 domain containing 1 (SASH1). Loss of the gene-internal marker D6S311, found in 30% of primary breast cancer, was significantly correlated with poor survival and increase in tumor size. Two SASH1 transcripts of approximately 4.4 and 7.5 kb exist and are predominantly transcribed in the human breast, lung, thyroid, spleen, placenta and thymus. In breast cancer cell lines, SASH1 is only expressed at low levels. SASH1 is downregulated in the majority (74%) of breast tumors in comparison with corresponding normal breast epithelial tissues. In addition, SASH1 is also downregulated in tumors of the lung and thyroid. Analysis of the protein domain structure revealed that SASH1 is a member of a recently described family of SH3/SAM adapter molecules and thus suggests a role in signaling pathways. We assume that SASH1 is a new tumor suppressor gene possibly involved in tumorigenesis of breast and other solid cancers. We were unable to find mutations in the coding region of the gene in primary breast cancers showing LOH within the critical region. We therefore hypothesize that other mechanisms as for instance methylation of the promoter region of SASH1 are responsible for the loss of expression of SASH1 in primary and metastatic breast cancer.
Similar articles
- Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A. Cvetkovic D, et al. Gynecol Oncol. 2004 Dec;95(3):449-55. doi: 10.1016/j.ygyno.2004.08.051. Gynecol Oncol. 2004. PMID: 15581945 - Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors.
Bilanges B, Varrault A, Basyuk E, Rodriguez C, Mazumdar A, Pantaloni C, Bockaert J, Theillet C, Spengler D, Journot L. Bilanges B, et al. Oncogene. 1999 Jul 8;18(27):3979-88. doi: 10.1038/sj.onc.1202933. Oncogene. 1999. PMID: 10435621 - Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer.
Rimkus C, Martini M, Friederichs J, Rosenberg R, Doll D, Siewert JR, Holzmann B, Janssen KP. Rimkus C, et al. Br J Cancer. 2006 Nov 20;95(10):1419-23. doi: 10.1038/sj.bjc.6603452. Epub 2006 Oct 31. Br J Cancer. 2006. PMID: 17088907 Free PMC article. - Chromosome 3p and breast cancer.
Yang Q, Yoshimura G, Mori I, Sakurai T, Kakudo K. Yang Q, et al. J Hum Genet. 2002;47(9):453-9. doi: 10.1007/s100380200064. J Hum Genet. 2002. PMID: 12202982 Review. - The emerging and diverse roles of the SLy/SASH1-protein family in health and disease-Overview of three multifunctional proteins.
Jaufmann J, Franke FC, Sperlich A, Blumendeller C, Kloos I, Schneider B, Sasaki D, Janssen KP, Beer-Hammer S. Jaufmann J, et al. FASEB J. 2021 Apr;35(4):e21470. doi: 10.1096/fj.202002495R. FASEB J. 2021. PMID: 33710696 Review.
Cited by
- The downregulation of SASH1 expression promotes breast cancer occurrence and invasion accompanied by the activation of PI3K-Akt-mTOR signaling pathway.
Li S, Su Y, Tian J, Wang K, Wang X, Ding L, Li C. Li S, et al. Sci Rep. 2024 Sep 19;14(1):21914. doi: 10.1038/s41598-024-72562-1. Sci Rep. 2024. PMID: 39300116 Free PMC article. - _NORAD_-Regulated Signaling Pathways in Breast Cancer Progression.
Capela AM, Tavares-Marcos C, Estima-Arede HF, Nóbrega-Pereira S, Bernardes de Jesus B. Capela AM, et al. Cancers (Basel). 2024 Feb 1;16(3):636. doi: 10.3390/cancers16030636. Cancers (Basel). 2024. PMID: 38339387 Free PMC article. Review. - Hepatitis B virus evades the immune system by suppressing the NF-κB signaling pathway with DENND2A.
Ide M, Tabata N, Yonemura Y, Murai K, Wang Y, Ishida A, Honda M, Kaneko S, Ito S, Yanagawa H. Ide M, et al. Microbiol Spectr. 2024 Mar 5;12(3):e0378523. doi: 10.1128/spectrum.03785-23. Epub 2024 Jan 19. Microbiol Spectr. 2024. PMID: 38240571 Free PMC article. - Uncovering a new SASH1 mutation associated with dyschromatosis universalis hereditaria using whole-exome-sequencing: A case report.
Yang Y, Jiang N, Mai JQ, Yang S, Xiao Y, Liu S. Yang Y, et al. Medicine (Baltimore). 2023 Aug 4;102(31):e34448. doi: 10.1097/MD.0000000000034448. Medicine (Baltimore). 2023. PMID: 37543808 Free PMC article. - Human Endogenous Retrovirus-H-Derived miR-4454 Inhibits the Expression of DNAJB4 and SASH1 in Non-Muscle-Invasive Bladder Cancer.
Park EG, Lee DH, Kim WR, Lee YJ, Bae WH, Kim JM, Shin HJ, Ha H, Yi JM, Cho SG, Choi YH, Leem SH, Cha HJ, Kim SW, Kim HS. Park EG, et al. Genes (Basel). 2023 Jul 7;14(7):1410. doi: 10.3390/genes14071410. Genes (Basel). 2023. PMID: 37510314 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials